Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
A Different Approach to Dermatology Care
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses:
- How they're positioning the company to capitalize on the unmet needs in other specific therapeutic areas
- Strategies to ensure long-term success in these spaces
- Patient centric initiatives they've implemented to ensure the patient voice is integrated into drug development and commercialization processes
- Their approach to orphan drug development
- Challenges and opportunities adapting to the US market
Recent Videos
Related Content
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Podcast
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
